Poly-4-hydroxybutyrate (P4HB): a new generation of resorbable medical devices for tissue repair and regeneration

Simon F. Williams 1 , Said Rizk 1  and David P. Martin 1
  • 1 Tepha, Inc., 99 Hayden Ave, Lexington, MA 02421, USA
Simon F. Williams, Said Rizk and David P. Martin


Poly-4-hydroxybutyrate (P4HB) is a thermoplastic, linear polyester, produced by recombinant fermentation, that can be converted into a wide range of resorbable medical devices. P4HB fibers are exceptionally strong, and can be designed to provide prolonged strength retention in vivo. In 2007, the FDA cleared a monofilament suture made from P4HB for general soft tissue approximation and/or ligation. Subsequently, surgical mesh devices for hernia repair, tendon and ligament repair, and plastic and reconstructive surgery have been introduced for clinical use. This review describes the unique properties of P4HB, its clinical applications, and potential uses that are under development.

  • [1]

    Albertsmeier M, Seiler CM, Fischer L, et al. Evaluation of the safety and efficacy of MonoMax® suture material for abdominal wall closure after primary midline laparotomy – a controlled prospective multicenter trial: ISSAAC [NCT005725079]. Langenbecks Arch Surg 2012; 397: 363–371.

  • [2]

    Angelos PC, Thakkar N, Sehgal A, Toriumi DM. Use of poly-4-hydroxybutyrate mesh in rhytidectomy: a retrospective review and cadaveric study of biomechanical strength testing. Presentation at the American Academy of Facial Plastic and Reconstructive Surgery Meeting, Washington DC, 2012.

  • [3]

    Bohl A, Rohm HW, Ceschi P, et al. Development of a specially tailored local drug delivery system for the prevention of fibrosis after insertion of cochlear implants into the inner ear. J Mater Sci Mater Med 2012; 23: 2151–2162.

  • [4]

    Bünger CM, Grabow N, Sternberg K, et al. A biodegradable stent based on poly(L-lactide) and poly(4-hydroxybutyrate) for peripheral vascular application: preliminary experience in the pig. J Endovasc Ther 2007; 14: 725–733.

  • [5]

    Martin DP, Badhwar A, Shah DV, et al. Characterization of poly-4-hydroxybutyrate mesh for hernia repair applications. J Surg Res 2013. Available at:http://dx.doi.org/10.1016/j.jss.2013.03.044.

  • [6]

    Doi Y. Microbial polyesters. New York, NY, USA: VCH 1990.

  • [7]

    Engelberg I, Kohn J. Physico-mechanical properties of degradable polymers used in medical applications: a comparative study. Biomaterials 1991; 12: 292–304.

  • [8]

    FDA clears first of its kind suture made using DNA technology, FDA News Release, Silver Spring, MD, USA, February 12, 2007.

  • [9]

    Grabow N, Bünger CM, Schultze C, et al. A biodegradable slotted tube stent based on poly(L-lactide) and poly(4-hydroxybutyrate) for rapid balloon-expansion. Ann Biomed Eng 2007; 35; 2031–2038.

  • [10]

    Hoerstrup S, Cummings I, Lachat M, et al. Functional growth in tissue-engineered living, vascular grafts: follow-up at 100 weeks in a large animal model. Circulation 2006; 114(Suppl I): I-159–I-166.

  • [11]

    Hoerstrup S, Sodian R, Daebritz S, et al. Functional living trileaflet heart valves grown in vitro. Circulation 2000; 102 (Suppl III): III-44–III-49.

  • [12]

    Houk KN, Jabbari A, Hall HK, Alemn C. Why delta-valerolactone polymerizes and gamma-butyrolactone does not. J Org Chem 2008; 73: 2674–2678.

  • [13]

    Klouda L, Vaz CM, Mol A, Baaijens FPT, Bouten CVC. Effect of biomimetic conditions on mechanical and structural integrity of PGA/P4HB and electrospun PCL scaffolds. J Mater Sci Mater Med 2008; 19: 1137–1144.

  • [14]

    Löbler M, Sternberg K, Stachs O, et al. Polymers and drugs suitable for the development of a drug delivery drainage system in glaucoma surgery. J Biomed Mater Res Part B Appl Biomater 2011; 97B: 388–395.

  • [15]

    Lock J. BioTREK™: The first completely bioabsorbable closure device. Presentation at Congenital and Structural Interventions Conference, Frankfurt, Germany, July 9, 2009.

  • [16]

    Martin DP, Williams SF. Medical applications of poly-4-hydroxybutyrate: a strong flexible absorbable biomaterial. Biochem Eng J 2003; 16: 97–105.

  • [17]

    Matthews B, Deeken C. Characterization of the mechanical strength and resorption properties of a novel fully absorbable material (poly-4-hydroxybutyrate – Phasix™) in a porcine model of hernia repair. Hernia 2012; 16(Suppl 1): S60.

  • [18]

    Nelson T, Kaufman E, Kline J, Sokoloff L. The extraneural distribution of gamma-hydroxybutyrate. J Neurochem 1981: 37: 1345–1348.

  • [19]

    Odermatt EK, Funk L, Bargon R, Martin DP, Rizk S, Williams SF. MonoMax suture: a new long-term absorbable monofilament suture made from poly-4-hydroxybutyrate. Int J Polym Sci 2012; 12, Article ID 216137.

  • [20]

    Peschel G, Dahse H-M, Konrad A, et al. Growth of keratinocytes on porous films of poly(3-hydroxybutyrate) and poly(4-hydroxybutyrate) blended with hyaluronic acid and chitosan. J Biomed Mater Res A 2008; 85: 1072–1081.

  • [21]

    Petralli N. Facial volumetric replacement, the secret of youth. 28th Annual Scientific Meeting of the American Academy of Cosmetic Surgery, Pre-Conference Symposium, Las Vegas, USA, January 17, 2012.

  • [22]

    Sendelbeck SL, Girdis CL. Disposition of a 14C-labeled bioerodible polyorthoester and its hydrolysis products, 4-hydroxybutyrate and cis, trans-1,4-bis(hydroxymethyl)cyclohexane in rats. Drug Metab Dispos 1985; 13: 291–295.

  • [23]

    Shieh S-J, Terada S, Vacanti JP. Tissue engineering auricular reconstruction: in vitro and in vivo studies. Biomaterials 2004; 25: 1545–1557.

  • [24]

    Stock U, Sakamoto T, Hatsuoka S, et al. Patch augmentation of the pulmonary artery with bioabsorbable polymers and autologous cell seeding. J Thorac Cardiovasc Surg 2000; 120: 1158–1167.

  • [25]

    Tornier announces launch of BioFiber® Surgical Mesh for tendon repair at arthroscopic surgery conference, Tornier Press Release, Edina, Minnesota, USA, http://www.tornier-us.com/news/press_view.php?pr_id=80, April 14, 2011.

  • [26]

    Van de Velde K, Kiekens P. Biopolymers: overview of several properties and consequences on their applications. Polymer Testing 2002; 21: 433–442.

  • [27]

    Weber B, Schoenauer R, Papadopulos F, et al. Engineering of living autologous human umbilical cord cell-based septal occlude membranes using composite PGA-P4HB matrices. Biomaterials 2011; 32: 9630–9641.

  • [28]

    Williams SF, Martin DP. Applications of PHAs in medicine and pharmacy. In: Doi Y, Steinbüchel A, editors. Weinheim, Germany: Biopolymers. Weinheim, Germany: Wiley-VCH 2002: 91–127.

  • [29]

    Xeltis announces approval to begin first clinical study of its tissue-engineered vascular grafts, Xeltis press release, Zürich, Switzerland, http://www.businesswire.com/news/home/20111206005075/en/Xeltis-Announces-Approval-Clinical-Study-Tissue-Engineered-Vascular, December 6, 2011.

  • [30]

    Xie H, Yashodhan YS, Shaffer BS. Chitosan hemostatic dressing for renal parenchymal wound sealing in a porcine model: implications for laparoscopic partial nephrectomy technique. JSLS 2008; 12: 18–24.

Purchase article
Get instant unlimited access to the article.
Log in
Already have access? Please log in.

Journal + Issues

Biomedical Engineering / Biomedizinische Technik (BMT) is a high-quality forum for the exchange of knowledge in the fields of biomedical engineering, medical information technology and biotechnology/bioengineering. BMT addresses engineers, natural scientists, and clinicians working in research, industry, or clinical practice. All articles are peer-reviewed.